Overview: In October 2020 United States' Packaged Medicaments exports accounted up to $2.13B and imports accounted up to $6.73B, resulting in a negative trade balance of $4.6B. Between October 2019 and October 2020 the exports of United States' Packaged Medicaments have increased by $162M (8.24%) from $1.97B to $2.13B, while imports decreased by $-212M (-3.05%) from $6.94B to $6.73B.
Growth: In October 2020, the increase in Packaged Medicaments's year-by-year exports was explained primarily by an increase in exports to China ($105M or 67.4%), Australia ($98.8M or 302%), and United Kingdom ($42.2M or 42.9%). In October 2020, the decrease in Packaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Switzerland ($-180M or -15.4%), Germany ($-169M or -19.2%), and Italy ($-168M or -36.2%).
This section shows Packaged Medicaments's exports and imports data at subnational level for United States. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Packaged Medicaments over time.
This section shows forecasts for total exports and imports, for Packaged Medicaments in United States. The forecast is based on a short-term, medium-term and long-term model using yearly trade data.